<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3915</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1750 - 1750</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.progesteroneRecepSummary<br/><br/>


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR) assay.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48,


    <em>Breast</em>. It was previously collected as Breast CS SSF # 2.
</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>0</td>
            <td class='code-desc'>PR negative</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>1</td>
            <td class='code-desc'>PR positive</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>7</td>
            <td class='code-desc'>Test ordered, results not in chart</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>9</td>
            <td class='code-desc'>Not documented in medical record<br/>
                Cannot be determined (indeterminate)<br/>
                PR (Progesterone Receptor) Summary status not assessed or unknown if assessed
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'></td>
            <td class='code-desc'></td>
        </tr>
    </table>
</div>
<div class='content chap10-para'>
    <div>
        <!--[if gte mso 10]>  <![endif]-->Note 1: Physician statement of PR (Progesterone Receptor) Summary status can be used to code this data item when no other information is available.<br/><br/>Note 2: The result of the PR test performed on the primary breast tissue is to be recorded in this data item.
        <br/><br/>Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of primary tumor.<br/><br/>Note 4: In cases where PR is reported on more than one breast tumor specimen, record the highest value. If any sample is positive, record as positive.<br/>&nbsp; &#8226; Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive specimens, code PR as negative (code 0).<br/><br/>Note 5: If neoadjuvant therapy is given, record the assay from tumor specimens prior to neoadjuvant therapy.<br/>&nbsp; &#8226; If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens, report the findings from post-treatment specimens.
        <br/><br/>Note 6: If the patient is PR positive and node negative, a multigene test such as Oncotype Dx may be performed, in which case another PR test will be performed. Do not record the results of that test in this field.
        <br/>&nbsp; &#8226; Record only the results of the test which made the patient eligible to be given the multigene test.
        <div>&nbsp;</div>
        <div>&nbsp;Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div>
    </div>
</div>